Flex Pharma Inc. (NASDAQ:FLKS) and Intec Pharma Ltd. (NASDAQ:NTEC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.
Valuation and Earnings
Table 1 shows the top-line revenue, earnings per share and valuation for Flex Pharma Inc. and Intec Pharma Ltd.
Table 2 hightlights the return on assets, net margins and return on equity of the two companies.
Insider and Institutional Ownership
The shares of both Flex Pharma Inc. and Intec Pharma Ltd. are owned by institutional investors at 13.7% and 40.23% respectively. Flex Pharma Inc.’s share owned by insiders are 16.9%. On the other hand, insiders owned about 16.08% of Intec Pharma Ltd.’s shares.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both